RotaShield: The Ill-Fated Rhesus-Human Reassortant Rotavirus Vaccine-Reference-Cited by-同舟云学术

RotaShield: The Ill-Fated Rhesus-Human Reassortant Rotavirus Vaccine

Published:2006-01 Issue:1 Volume:35 Page:44-50
ISSN:0090-4481
Container-title:Pediatric Annals
language:en
Short-container-title:Pediatr Ann

Author:

Matson David O

Publisher

SLACK, Inc.

Subject

Pediatrics, Perinatology, and Child Health

Reference38 articles.

1. 1. Jenner EI. Inquiry into the causes and effects ofthe varioloevaccinoe or cow-pox. 1798. In: Eliot C ed. The Three Original Publications on Vaccination Against Smallpox. New York NY: P.P. Collier & Son; 1909.

2. 2. Withdrawal of Rotavims Vaccine live Oral Tetravalent (RotaShield) Food and Drug Administration. 2002. Available at: http://www. fda.gov/cber/recalls/rotal01599.htm.Accessed November 29 2005.

3. 3. Kapikian AZ Flores J Hoshíno Y et al. Rotavirus: the major etìologic agent of severe infantile diarrhea may be controllable by a "Jennerian" approach to vaccination. J Infect Dis. 1986;153(5):815-822.

4. 4. Kapikian AZ Wyatt RG Greenberg HB et al. Approaches to immunization of infants and young children against gastroenteritis due to rotaviruses. Rev Infect Dis. 1980;2(3):459469.

5. 5. Flores J Perez-Schael I Gonzalez M et al. Protection against severe rotavirus diarrhoea by rhesus rotavirus vaccine in Venezuelan infents. Lancet. 1987; 1(8538): 882-884.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A randomized, double-blind, placebo-controlled phase I clinical trial of rotavirus inactivated vaccine (Vero cell) in a healthy adult population aged 18–49 years to assess safety and preliminary observation of immunogenicity;Vaccine;2024-07

2. Success from the South: the rotavirus vaccine story and its lessons;The Lancet;2024-01

3. COVID-19 Vaccination Hesitancy among Healthcare Workers—A Review;Vaccines;2022-06-15

4. Rotaviruses;Virus Research;2014-09

5. Vaccines;Clinical Immunology;2013